WuXi Biologics (Cayman) Inc. (WXXWY)
USD 4.3
(-1.15%)
USD 4.3
(-1.15%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 17.03 Billion | 15.26 Billion | 10.29 Billion | 5.61 Billion | 3.98 Billion | 2.53 Billion |
| Cost of Revenue | 10.2 Billion | 8.54 Billion | 5.46 Billion | 3.07 Billion | 2.32 Billion | 1.51 Billion |
| Gross Profit | 6.82 Billion | 6.72 Billion | 4.82 Billion | 2.53 Billion | 1.65 Billion | 1.01 Billion |
| Operating Expenses | 2.87 Billion | 1.41 Billion | 854.61 Million | 605.33 Million | 588.21 Million | 368.8 Million |
| Selling, General and Administrative Expenses | 2.08 Billion | 1.69 Billion | 1.13 Billion | 721.96 Million | 451.08 Million | 326.09 Million |
| Research and Development Expenses | 792.57 Million | 689.57 Million | 507.83 Million | 308.97 Million | 260.95 Million | 169.28 Million |
| Other Expenses | - | 17.94 Million | 837 Thousand | 4.38 Million | -1.97 Million | 2.67 Million |
| Cost and Expenses | 13.08 Billion | 9.96 Billion | 6.31 Billion | 3.68 Billion | 2.91 Billion | 1.88 Billion |
| Operating Income | 3.94 Billion | 4.35 Billion | 3.17 Billion | 1.5 Billion | 947.96 Million | 522.37 Million |
| Interest Expense | 158.48 Million | 64.38 Million | 39.19 Million | 42.73 Million | 19.6 Million | - |
| Income Tax Expense | 603.17 Million | 807.86 Million | 484.53 Million | 273.06 Million | 116.29 Million | 107.25 Million |
| Earnings before Tax | 4.17 Billion | 5.35 Billion | 3.99 Billion | 1.96 Billion | 1.12 Billion | 737.72 Million |
| Net Income | 3.39 Billion | 4.42 Billion | 3.38 Billion | 1.68 Billion | 1.01 Billion | 630.59 Million |
| Earnings Per Share Basic | 0.77 | 1.06 | 0.81 | 0.43 | 0.27 | 0.16 |
| Earnings Per Share Diluted | 0.78 | 1.01 | 0.77 | 0.40 | 0.25 | 0.16 |
| Weighted Average Shares Outstanding | 4.4 Billion | 4.37 Billion | 4.4 Billion | 4.2 Billion | 3.99 Billion | 3.94 Billion |
| Weighted Average Shares Outstanding (Diluted) | 4.34 Billion | 4.37 Billion | 4.42 Billion | 4.2 Billion | 3.99 Billion | 3.94 Billion |
| Gross Margin | 0.40 | 0.44 | 0.47 | 0.45 | 0.42 | 0.40 |
| EBIT Margin | 0.32 | 0.33 | 0.35 | 0.32 | 0.29 | 0.26 |
| Profit Margin | 0.20 | 0.29 | 0.33 | 0.30 | 0.25 | 0.25 |
| EBITDA | 5.5 Billion | 5.06 Billion | 3.62 Billion | 1.77 Billion | 1.14 Billion | 663.9 Million |
| Earnings Before Tax Margin | 0.23 | 0.28 | 0.31 | 0.27 | 0.24 | 0.21 |
| Breakdown | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Revenue | 8.57 Billion | 17.03 Billion | 8.54 Billion | 8.49 Billion | 15.26 Billion | 8.06 Billion |
| Cost of Revenue | 5.22 Billion | 10.2 Billion | 5.27 Billion | 4.93 Billion | 8.54 Billion | 4.75 Billion |
| Gross Profit | 3.34 Billion | 6.82 Billion | 3.26 Billion | 3.56 Billion | 6.72 Billion | 3.31 Billion |
| Operating Expenses | 1.53 Billion | 2.37 Billion | 1.62 Billion | 1.02 Billion | 1.41 Billion | 904.92 Million |
| Selling, General and Administrative Expenses | 1.18 Billion | - | 1.17 Billion | 915.69 Million | - | 1.04 Billion |
| Research and Development Expenses | 344.06 Million | - | 451.13 Million | 341.44 Million | - | 418.44 Million |
| Other Expenses | - | 16.96 Million | - | - | 17.94 Million | - |
| Cost and Expenses | 6.75 Billion | 12.58 Billion | 6.89 Billion | 5.95 Billion | 9.96 Billion | 5.65 Billion |
| Operating Income | 1.81 Billion | 3.93 Billion | 1.64 Billion | 2.3 Billion | 4.35 Billion | 1.86 Billion |
| Interest Expense | - | 158.48 Million | - | - | 64.38 Million | - |
| Income Tax Expense | 228.06 Million | 603.17 Million | 412.06 Million | 191.11 Million | 807.86 Million | 498.95 Million |
| Earnings before Tax | 2 Billion | 4.17 Billion | 1.64 Billion | 2.52 Billion | 5.35 Billion | 2.42 Billion |
| Net Income | 1.49 Billion | 3.39 Billion | 1.13 Billion | 2.26 Billion | 4.42 Billion | 1.88 Billion |
| Earnings Per Share Basic | 0.35 | - | 0.25 | 0.52 | - | 0.43 |
| Earnings Per Share Diluted | 0.35 | - | 0.26 | 0.52 | - | 0.43 |
| Weighted Average Shares Outstanding | 4.3 Billion | 4.4 Billion | 4.48 Billion | 4.35 Billion | 4.37 Billion | 4.38 Billion |
| Weighted Average Shares Outstanding (Diluted) | 4.25 Billion | 4.34 Billion | 4.34 Billion | 4.34 Billion | 4.37 Billion | 4.36 Billion |
| Gross Margin | 0.39 | 0.40 | 0.38 | 0.42 | 0.44 | 0.41 |
| EBIT Margin | 0.29 | - | 0.27 | 0.31 | - | 0.27 |
| Profit Margin | 0.17 | 0.20 | 0.13 | 0.27 | 0.29 | 0.23 |
| EBITDA | 2.47 Billion | - | 2.26 Billion | 2.66 Billion | - | 2.16 Billion |
| Earnings Before Tax Margin | 0.21 | 0.23 | 0.19 | 0.27 | 0.28 | 0.23 |
3738
NHAWF
PTABF
CLGOF
OTM
AVIV